https://www.globenewswire.com/news-release/2021/06/23/2251610/0/en/Amunix-Appoints-Industry-Veteran-Frank-Watanabe-to-its-Board-of-Directors.html
https://www.globenewswire.com/news-release/2021/04/12/2208186/0/en/Amunix-Presents-Preclinical-Data-at-American-Academy-of-Cancer-Research-AACR-Annual-Meeting-from-Lead-Program-AMX-818-Demonstrating-Robust-Efficacy-in-HER2-Tumor-Models-and-Enhance.html
https://www.globenewswire.com/news-release/2021/03/04/2187044/0/en/Amunix-Raises-117-Million-Series-B-Financing-to-Fund-its-Oncology-Pipeline.html
https://www.fiercebiotech.com/biotech/amunix-scores-117m-to-fuel-t-cell-engagers-cytokines-for-solid-tumors#:~:text=Biotech-,Amunix%20scores%20%24117M%20to%20fuel%20T,engagers%2C%20cytokines%20for%20solid%20tumors&text=Exactly%20one%20year%20after%20Amunix,from%20the%20venture%20capital%20well.
https://www.fiercebiotech.com/research/esmo-amunix-s-t-cell-engagers-shrink-solid-tumors-animal-models
https://www.globenewswire.com/news-release/2020/06/22/2051294/0/en/Amunix-to-Present-Preclinical-Data-on-HER2-and-EGFR-Targeted-T-Cell-Engagers-at-AACR-Virtual-Annual-Meeting-II.html
https://www.fiercebiotech.com/biotech/amunix-raises-73m-to-take-t-cell-engager-into-humans
https://www.globenewswire.com/news-release/2020/03/04/1994979/0/en/Amunix-Raises-73-Million-in-Series-A-Financing-Led-by-Omega-Funds.html